Additionally, advantages of using ritlecitinib may avoid side effects of pan-JAK inhibitors, such as increased cholesterol and liver enzymes, and those related to JAK2 inhibition, including thrombocytopenia and anemia. Here, JAK2 is linked to anemia (phenotype).